The HCV core protein acts as a positive regulator of Fas-mediated apoptosis in a human lymphoblastoid T cell line

Virology

Volumn 276, Issue 1, 2000, Pages 127-137

  Hahn, Chang S ^a,b   Cho, Young Gyu ^a   Kang, Beom Sik ^a   Lester, Isabel M ^a   Hahn, Young S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; FAS ANTIGEN; FAS LIGAND; REGULATOR PROTEIN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS CORE;

EID: 0034633835     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0541     Document Type: Article

References (55)

1. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets
2. Hepatitis C virus is detected in a monocyte/macrophage subpopuladen of peripheral blood mononuclear cells of infected patients
3. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice
4. Structure of replicating hepatitis C virus (HCV) quasispecies in the liver may not be reflected by analysis of circulating HCV virions
5. Immunopathology of hepatitis C
6. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
7. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
8. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
9. Expression and identification of hepatitis C virus polyprotein cleavage products
10. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis
11. Non-A, non-B hepatitis viruses
12. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
13. Hepatitis C viruses
14. Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K
15. Analysis of the cell tropism of HCV by using an in vitro HCV-infected human lymphocytes and hepatocytes
16. Fas-induced DNA fragmentation and proteolysis of nuclear proteins
17. Induction of cell death by myristylated death domain of p55 TNF receptor is not abolished by Ipr-cg-like point mutation in death domain
18. The role of immune responses in the pathogenesis of hepatitis C virus infection
19. Suppression of host immune response by the core protein of hepatitis C virus: Possible implication for HCV persistence
20. Differential subcellular localization of hepatitis C virus core gene products
21. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents
22. Activation of p53 tumor suppressor by hepatitis C virus core protein
23. Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma
24. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation
25. Homotypic interaction and multimerization of hepatitis C virus core protein
26. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor
27. Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2
28. Inactivation of the small GTP binding protein Rho induces multinucleate cell formation and apoptosis in murine T lymphoma EL4
29. Molecular cloning and characterization of human caspase-activated DNase
30. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication
31. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
32. Apoptosis by death factor
33. The Fas death factor
34. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients
35. Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver
36. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses
37. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein
38. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype
39. Suppression of apoptotic cell death by hepatitis C virus core protein
40. Transcriptional repression of p53 promoter by hepatitis C virus core protein
41. Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein
42. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
43. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection
44. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein
45. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma
46. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis
47. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation
48. Evidence for in vitro replication of hepatitis C virus genome in a human T cell line
49. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro
50. Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication
51. The N-end rule
52. + T helper 1 effectors
53. Cloning by limiting dilution
54. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis
55. Infection of peripheral mononuclear blood cells by hepatitis C virus